Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
T
|
Tencent Holdings Ltd
F:NNN1
|
CN |
|
Onmobile Global Ltd
NSE:ONMOBILE
|
IN |
|
Aisan Industry Co Ltd
TSE:7283
|
JP |
|
F
|
Fine Organic Industries Ltd
BSE:541557
|
IN |
|
People.cn Co Ltd
SSE:603000
|
CN |
|
SAP SE
NYSE:SAP
|
DE |
|
T
|
Tencent Holdings Ltd
XMUN:NNN1
|
CN |
|
Crimson Wine Group Ltd
OTC:CWGL
|
US |
|
Weave Communications Inc
NYSE:WEAV
|
US |
|
K
|
Kinross Gold Corp
LSE:0R2D
|
CA |
|
Chesapeake Energy Corp
NASDAQ:CHK
|
US |
|
Colefax Group PLC
LSE:CFX
|
UK |
|
Apex Frozen Foods Ltd
NSE:APEX
|
IN |
|
Azeus Systems Holdings Ltd
SGX:BBW
|
HK |
|
U
|
United Parcel Service Inc
DUS:UPAB
|
US |
Bankruptcy Probability
Mink Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mink Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
52.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mink Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mink Therapeutics Inc has total debt of 5.2m USD. This includes both short-term (5.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
